Impact Biomedical (IBO) Return on Equity [ROE] (2023 - 2026)
Impact Biomedical (IBO) posted Return on Equity [ROE] of 11.74% for Q3 2026, up 6.34 percentage points from the prior quarter.
Powered by 
Analysis
Impact Biomedical (IBO) Return on Equity [ROE] (2023 - 2026) Analysis & Trends
For FY2025, Impact Biomedical's Return on Equity [ROE] came in at -104.16%, up 35.39 percentage points from FY2024.
- In prior years, Impact Biomedical's Return on Equity [ROE] was -139.55% in FY2024 (-125.09 pp) and -14.47% in FY2023.
- The Q3 2026 figure stands as the highest quarterly Return on Equity [ROE] in data going back to Q1 2023.
- On a year-over-year basis, Return on Equity [ROE] increased in 1 of the last four quarters, with an average year-over-year change of -101.91 percentage points.
- According to Business Quant data, Return on Equity [ROE] for the three prior quarters was 5.40% (Q2 2026), -85.09% (Q1 2026) and -354.22% (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn | 74.39% |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn | 19.33% |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn | - |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn | 5.63% |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - | - |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn | 21.60% |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn | 72.13% |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn | -31.17% |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn | 4.66% |
| 10 | Impact Biomedical | 43.92 Mn | 47.11 Mn | 15,000.00 | 11.74% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 11.74% |
| Jun 30, 2026 | 5.40% |
| Mar 31, 2026 | -85.09% |
| Dec 31, 2025 | -354.22% |
| Mar 31, 2025 | -356.72% |
| Dec 31, 2024 | -119.14% |
| Sep 30, 2024 | 3.62% |
| Jun 30, 2024 | -16.11% |
| Mar 31, 2024 | -16.41% |
| Dec 31, 2023 | -15.24% |
| Sep 30, 2023 | -21.61% |
| Jun 30, 2023 | -24.22% |
| Mar 31, 2023 | -22.48% |
API Access
Impact Biomedical Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=IBO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "IBO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=IBO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();